ESR1 and inflammatory breast carcinoma: Initially, this patient had ER+ Her2+ invasive ductal carcinoma (IDC) in the left breast that was treated with standard local therapies over 2 years and this patient subsequently developed triple-negative IBC in the same breast [16] (Supplementary Information).